108 related articles for article (PubMed ID: 21855385)
1. [First epidemiologic data about phloroglucinol exposure during first trimester of pregnancy].
Lacroix I; Hurault-Delarue C; Kessler S; Guitard C; Vidal S; Albouy-Cossard C; Montastruc JL; Damase-Michel C
Gynecol Obstet Fertil; 2011 Dec; 39(12):694-7. PubMed ID: 21855385
[TBL] [Abstract][Full Text] [Related]
2. First epidemiological data for venotonics in pregnancy from the EFEMERIS database.
Lacroix I; Beau AB; Hurault-Delarue C; Bouilhac C; Petiot D; Vayssière C; Vidal S; Montastruc JL; Damase-Michel C
Phlebology; 2016 Jun; 31(5):344-8. PubMed ID: 26060062
[TBL] [Abstract][Full Text] [Related]
3. [Drug in pregnancy: studies in the French database EFEMERIS].
Damase-Michel C; Lacroix I; Hurault-Delarue C; Beau AB; Montastruc JL;
Therapie; 2014; 69(1):91-100. PubMed ID: 24698193
[TBL] [Abstract][Full Text] [Related]
4. [Drugs in pregnancy: study in the EFEMERIS database (2004 to 2008)].
Hurault-Delarue C; Lacroix I; Vidal S; Montastruc JL; Damase-Michel C
Gynecol Obstet Fertil; 2011 Oct; 39(10):554-8. PubMed ID: 21924656
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid monotherapy in pregnancy and major congenital malformations.
Jentink J; Loane MA; Dolk H; Barisic I; Garne E; Morris JK; de Jong-van den Berg LT;
N Engl J Med; 2010 Jun; 362(23):2185-93. PubMed ID: 20558369
[TBL] [Abstract][Full Text] [Related]
6. [In utero exposure to benzodiazepine. Is there a risk for anal atresia with lorazepam?].
Bonnot O; Vollset SE; Godet PF; d'Amato T; Dalery J; Robert E
Encephale; 2003; 29(6):553-9. PubMed ID: 15029090
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy outcome of women inadvertently exposed to ribostamycin during early pregnancy: a prospective cohort study.
Lee SW; Han JY; Choi JS; Chung JH; Kim MY; Yang JH; Koong MK; Nava-Ocampo AA; Koren G
Reprod Toxicol; 2009 Apr; 27(2):196-8. PubMed ID: 19162171
[TBL] [Abstract][Full Text] [Related]
8. Safety of oseltamivir during pregnancy: a comparative study using the EFEMERIS database.
Beau AB; Hurault-Delarue C; Vial T; Montastruc JL; Damase-Michel C; Lacroix I
BJOG; 2014 Jun; 121(7):895-900. PubMed ID: 24512604
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity.
Schaefer C
Birth Defects Res A Clin Mol Teratol; 2003 Aug; 67(8):591-4. PubMed ID: 14632309
[TBL] [Abstract][Full Text] [Related]
10. Risk of Pregnancy Termination and Congenital Anomalies After Domperidone Exposure: A Study in the EFEMERIS Database.
Araujo M; Vabre C; Benevent J; Sommet A; Damase-Michel C; Hurault-Delarue C; Lacroix I
Drug Saf; 2021 Jul; 44(7):787-796. PubMed ID: 33970448
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study.
Gur C; Diav-Citrin O; Shechtman S; Arnon J; Ornoy A
Reprod Toxicol; 2004; 18(1):93-101. PubMed ID: 15013068
[TBL] [Abstract][Full Text] [Related]
12. Increased rate of major malformations in offspring exposed to valproate during pregnancy.
Wyszynski DF; Nambisan M; Surve T; Alsdorf RM; Smith CR; Holmes LB;
Neurology; 2005 Mar; 64(6):961-5. PubMed ID: 15781808
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of increased congenital malformations after first trimester exposures to angiotensin-converting enzyme inhibitors.
Cooper WO
J Cardiovasc Nurs; 2008; 23(1):20-4. PubMed ID: 18158502
[TBL] [Abstract][Full Text] [Related]
14. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies.
Park-Wyllie L; Mazzotta P; Pastuszak A; Moretti ME; Beique L; Hunnisett L; Friesen MH; Jacobson S; Kasapinovic S; Chang D; Diav-Citrin O; Chitayat D; Nulman I; Einarson TR; Koren G
Teratology; 2000 Dec; 62(6):385-92. PubMed ID: 11091360
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services.
Garbis H; Elefant E; Diav-Citrin O; Mastroiacovo P; Schaefer C; Vial T; Clementi M; Valti E; McElhatton P; Smorlesi C; Rodriguez EP; Robert-Gnansia E; Merlob P; Peiker G; Pexieder T; Schueler L; Ritvanen A; Mathieu-Nolf M
Reprod Toxicol; 2005; 19(4):453-8. PubMed ID: 15749258
[TBL] [Abstract][Full Text] [Related]
16. Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database.
Lacroix I; Hurault C; Sarramon MF; Guitard C; Berrebi A; Grau M; Albouy-Cossard C; Bourrel R; Elefant E; Montastruc JL; Damase-Michel C
Eur J Clin Pharmacol; 2009 Aug; 65(8):839-46. PubMed ID: 19365629
[TBL] [Abstract][Full Text] [Related]
17. The safety of metoclopramide use in the first trimester of pregnancy.
Matok I; Gorodischer R; Koren G; Sheiner E; Wiznitzer A; Levy A
N Engl J Med; 2009 Jun; 360(24):2528-35. PubMed ID: 19516033
[TBL] [Abstract][Full Text] [Related]
18. A study of the teratogenic and fetotoxic effects of large doses of chlordiazepoxide used for self-poisoning by 35 pregnant women.
Gidai J; Acs N; Bánhidy F; Czeizel AE
Toxicol Ind Health; 2008; 24(1-2):41-51. PubMed ID: 18818180
[TBL] [Abstract][Full Text] [Related]
19. The safety of cetirizine during pregnancy. A prospective observational cohort study.
Weber-Schoendorfer C; Schaefer C
Reprod Toxicol; 2008 Sep; 26(1):19-23. PubMed ID: 18571373
[TBL] [Abstract][Full Text] [Related]
20. Major congenital malformations after first-trimester exposure to ACE inhibitors.
Cooper WO; Hernandez-Diaz S; Arbogast PG; Dudley JA; Dyer S; Gideon PS; Hall K; Ray WA
N Engl J Med; 2006 Jun; 354(23):2443-51. PubMed ID: 16760444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
